WASHINGTON — The 'gotcha' culture that sparked an exodus of HME providers from the Joint Commission on Accreditation of Health-care organizations (JCAHO) in recent years may be on the verge of extinction.
CANTON, Mass. - Disease state management isn't so widespread as to be a must for HME providers. But until some provider develops a purer brand of oxygen, DSM does offer a competitive advantage, say industry watchers.
FLORISSANT, Mo. — Most of the rehab world got its first peek at the new rehab-specific accreditation standards of the Accreditation Commission for Health Care (ACHC) in late October with the unveiling of the ACHC rehab accreditation manual at Medtrade.
BRENTWOOD, Tenn. — American HomePatient, which filed for bankruptcy in July, took some heat in September from creditors, who tried to block compensation and severance package between the company and its senior management.
WASHINGTON - FDA advisers last month called a new drug from Pfizer Boehringer Ingelheim safe and effective for opening the airways of patients with COPD, America's No. 4 killer, U.S. advisers said last month.
WASHINGTON — A September report from the OIG estimates that 61% of Medicare claims for DME products that sport surrogate UPINs should have used permanent UPINs, and it suggests that CMS take a harder look at claims with surrogate numbers.